Announced
Atrys to acquire Lenitudes for €16.6m.
Synopsis
Atrys, a biomedical company focused on developing new tools for diagnosis and personalized treatment of cancer and precancerous diseases, agreed to acquire Lenitudes, a medical center & research company, for €16.6m. With this acquisition, Atrys begins its European expansion with the entry into Portugal, which will be its second market in the continent.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.